|
|
NewsMFI Successfully Used to Analyze High Concentration MAb'sNew Application Note Now Available High concentration (>60 mg/ml) MAb formulations are becoming increasingly popular with biopharma companies for their therapeutic benefits. Unfortunately they are more susceptible to protein particle formation and aggregation. They are also difficult, if not impossible, to analyze with traditional particle counters. MFI overcomes these challenges and provides particle size distributions, concentrations and particle images. Please contact Brightwell for a copy of our Application Note and more information. The Application Note is also available from the Customers pages here on our web site. |